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microorganisms, cells and animals to make useful proteins’. 
However, in their final expanded, revised and updated form 
they succeed in providing a worthwhile contribution to the 
current understanding of this aspect of biotechnology. This 
book discusses the nature and importance of the production 
of therapeutically tlseful proteins in greater depth than the 
general books on biotechnology on the market and thus will 
be helpful in providing a comparatively recent ‘state of the 
art’ picture for research workers in this field. Althougil osten- 
sibly a specialised book it will also be useful to final year 
undergraduates as a reference source for some of the applica- 
tions of genetic engineering. Although the index is rather 
limited for a book of this depth of content, there is a useful 
table of contents and the individual chapters are well 
documented. 
There are three main areas of subject material in this book: 
microbial systems and mammalian systems for protein pro- 
duction and thirdly the discovery, design and usage of pro- 
teins as therapeutic agents. It is of considerable interest that 
yeast systems are now being used successfully in the produc- 
tion of proteins for clinical use, such as human serum albumin 
(HSA) and this is discussed in chapter 5. Chapter 3 describes 
the development of vaccines, in particular against the human 
hepatis B virus by the expression of the viral surface antigen 
protein (HBsAg) in transformed yeast. The use of yeast secre- 
tion vectors to express the domains (modules) of mosaic pro- 
teins, such as those from the blood clotting pathway, with 
secretion directly into the extracellular medium is examined in 
chapter 4. 
Tissue-type plasminogen activator (t-PA) is a protein of 
great therapeutic potential. It activates pIasminogen to the 
plasmin required to lyse the blood clots, in the coronary 
artery, that are a contributory factor to acute myocardial in- 
farction. The expression of t-PA and related enzymes in mam- 
malian cells is discussed in chapters 6 and 8 and the 
remarkable possibility of producing t-PA in the milk of tran- 
sgenic animais is examined in chapter 11. 
Proteins are amongst the largest drugs used and in contrast 
to most therapeutic agents a protein molecule is not fully 
defined by its ‘chemical formula’. This is because the tertiary 
structure can not as yet be fully predicted from the known 
amino acid sequence. The potential and problems of proteins 
as therapeutic agents and their selective delivery and targeting 
are the subjects of chapters 17 and 16, respectively. In chapter 
14 the importance of recombinant receptor protein analysis in 
the rational design of drugs at the molecular level is debated. 
This interesting book clearly indicates the great potential 
and diversity of the production of therapeutically useful pro- 
teins by biotechnology. These include insulin, growth hor- 
mone, HSA, HBsAg, t-PA and erythropoietin (chapter 15), 
which are now available through the powerful methods of 
biotechnology as applied to a variety of microbial and mam- 
malian cellular systems. 
Helen Wiseman 
Short Protocols in Molecular Biology; Edited by F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seid- 
man, J.A. Smith and K. Struhl; John Wiley; New York, 1989; xxii + 387 pages; X31.65 
This laboratory manual, spirally bound so that it lies flat on 
the bench and with a very arty cover, is a condensed version 
of the extremely weighty Current Protocols in Molecular 
Biology. A comparison of the two quickly reveals that they 
contain essentially the same set of recipes. What this new ver- 
sion lacks is the italics present in Current Protocols explaining 
why a particular step is of importance. For example, the 
description of how to make RNA from animal tissue is iden- 
tical but you are not told in the Short Protocols why Sarkosyl 
is excluded from the homogenisation step (a frothy mess will 
result!). Having reviewed and used Current Protocols I think 
that this is a pity as an understanding of the potential pitfalls 
of a technique is a key part of using it successfully. All of the 
standard techniques of molecular biology are covered in the 
book with the exception of the polymerase chain reaction 
which is mentioned but not in anything like the detail which 
its widespread use these days would warrant. I found this a 
curious oversight particularly when this series is supposed to 
be updated on a quarterly basis; in 1989 (when it was publish- 
ed) which lab did not have a PCR machine? Like its parent 
volume, Short Protocols is an easy book to use and has some 
of the same clear diagrams. It contains a useful glossary and 
recipe section and a limited, but worthwhile reference section. 
Short Protocols is, as it claims to be, a book designed for 
those who are familiar with the principles but want the basic 
steps. I cannot really see the circumstances under which 
anyone would want to have both of these books but either of 
them would make a useful contribution to the lab. I have to 
say that f31.65 is rather expensive for a spirally bound book 
but it is still one-third of the price of Current Protocols. 
Keith Dudley 
Cellular and Molecular Biology of Muscle Development; Edited by L.H. Kedes and F.E. Stockdale; Alan R. Liz,; 
New York, 1989; xxxv + 1059 pages, $195.00. 
Sometimes the grass is greener in the neighbouring scientific 
plot though I cannot pretend to have found it so in the case 
of muscle developmental biology. The field used to resemble 
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a bog. This book shows that the scene has changed: there are 
decent islands of firm ground, patches of green are appearing. 
This is primarily due to the application of molecular genetics, 
Volume 268, number 2 FEBS LETTERS August 1990 
and it is notable that the more molecular genetic-like the ar- 
ticles are in this book, the more compelling they are. Doing 
hybridisations extends the range of developmental observa- 
tions beyond what is possible with antibodies, but it does not 
really grasp the problem. Getting at the muscle-specific se- 
quences of the flanking regions of muscle protein genes does. 
So does the use of ~rosoptzi~a and C. ejegans to introduce mu- 
tant proteins and thereby dissect the assembly of filaments 
and ultimately the contractile process. 
Still, it has to be said that 86 contributions amounting to 
over a thousand pages of a camera-ready format (albeit on 
glossy paper) derived from a conference is a pretty daunting 
prospect. What are the major topics? Let us suppose there are 
about four muscle development stages: commitment leading 
to myoblast proliferation, cessation of division leading to 
myotube formation, one or more stages of embryonic and 
adult development and plasticity. Further assume there are 
five major gene families: myosin, actin, troponin- 
tropomyosin, cytoskeleton proteins, extracellular matrix pro- 
teins. Lastly, suppose there are four animals of major interest: 
man, mouse, fruit fly, nematode. Multiplication of these 
three factors would yield a number of topics which is not far 
short of the number of contributions and comes close to the 
list of contents, especially as the last chapter is on human mus- 
cle disease. Of course the spread is not actually even; myosin 
and actin are more popular than the other proteins, deveiop- 
ment per se is more closely studied in vertebrates and so on. 
What is surprisingly missing is most of the MyoD story, the 
observation that one gene is responsible for terminal differen- 
tiation and the sequels to this observation. While much of this 
story unravelled in 1989 and 1990, it must have been a hot 
topic at the time of the conference in April 1988. 
For anyone in the field this is an essential volume, though 
probably for the library at the price. For anyone in a 
neighbouring field, it is strongly recommended: perseverance 
brings its reward. 
R.M. Simmons 
The Use of HPLC in Receptor Biochemistry; Editing A.R. Kerlavage; Alan R. Liss; New York, 1989; x + 256 pages; 
$96.00 
One of the most difficult tasks today facing the scientist stu- 
dying receptors is correlating volumes of biological and phar- 
macological evidence, obtained over several decades, with 
newly determined receptor sequences, obtained only in the 
last seven years. During roughly the same time HPLC has 
matured into an extremely powerful tool for purifying and 
studying the structure of proteins and peptides. Scientists 
discovered that the same techniques used to study soluble pro- 
teins could be applied to membrane receptors and as purified 
receptor proteins became available in reasonable quantity. 
The articles presented in this volume are written by scien- 
tists who have had many years of experience with HPLC, both 
with receptors and with other systems. The purpose of this 
volume is to provide for those interested in the study of recep- 
tors a background in HPLC methodology and examples of 
some of the advances made in the receptor field as a result of 
its application. There is an excellent technical summary of 
HPLC and a discussion of the various modes of the HPLC 
which are most applicable to particular problems, and in- 
cluding such details as a list of packing materials available, 
suppliers, function(s) of the packing material, etc. The use of 
HPLC in the synthesis, purification and characterisation of 
synthetic peptides is discussed in very good detail. Synthetic 
peptides have become increasingly important in the receptor 
field, being used to elicit specific antibodies to known receptor 
sequences, as ligands to study peptide receptors, and as in- 
hibitors of the interactions between receptors and other pro- 
teins. The isolation of endogenous peptides is described, with 
emphasis upon maintaining biological activity, and also the 
mapping of receptors using HPLC techniques, which has 
greatly advanced the knowledge of receptor structure and 
function. There is a detailed discussion of the application of 
a side range of HPLC modes to the study of steroid hormone 
receptors. The final chapter presents a highly detailed strategy 
for isolating small amounts of proteins and peptides for 
microsequence analysis. 
At the conclusion of each chapter there is an extensive 
bibliography with almost all the references cited being of re- 
cent date, and including the titles of the papers quoted. In all 
chapters there are a number of examples discussed in detail, 
including a reference to some of the problems that a novice 
entering the field of HPLC for the first time may encounter, 
and also comprehensive references to others. 
‘This clearly written and well-organised volume represents a 
bringing together of information concerning the techniques 
and applications of HPLC in the efforts to determine the links 
between the structure and observed biology of nlembrane 
receptors. lt should prove a valuable aid to those engaged in, 
or considering entry into, this field. It is highly recommended, 
in particular to those who wish to bring themselves up-to-date 
in this area of membrane research, and also to those who wish 
to become aware of the problems/difficult~es with the use of 
the technique. 
Norma M. Ryan 
Biophysical Chemistry of Membrane Function; A. Kotyk, K. JanaEek and J. Koryta; John Wiley, Chichester, 1988; 
xvii + 377 pages; f45.00 
This textbook because of its interdisciplinary requirements 
has contributions by three authors although a great deal of the 
book is nevertheless written by Professor Kotyk. The 
biomembrane field in fact requires such an interdisciplinary 
approach both in its research endeavours and for its presenta- 
tion. Physicists, biochelnists, physiologists, cell biologists and 
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